The central nervous system (CNS) remains an important frontier in the study of HIV disease, since the CNS is a potential reservoir of virus that is relatively inaccessible to anti-retroviral therapy, and since the mechanism of the development of HIV dementia is still not completely understood. In this program project application we propose to continue our studies of HIV dementia (HIVD) with projects that will be supported by cores. In one project. Dr. F. Gonzalez-Scarano will continue his studies of neurotropism using primary cultures of CNS cells, and specifically microglia, and map the determinants of fusion in microglial. In another project Dr. W. Kerr will use a SCID-hu mouse model to study trafficking of bone-marrow derived cells into the CNS, to determine the potential influence of HIV infection in this trafficking, and to begin in vivo studies on the pathophysiology and therapy of CNS disease. In another project, Dr. D. Kolson will develop new strategies for gene therapy of CNS cells, taking particular advantage of 'reverse pseudotypes' a system that he and collaborators developed recently, to kill HIV infected cells, and to develop neuroprotective approaches to therapy of HIVD. Still yet another project, which will be headed by Dr. R. Pomerantz, will study the effects of down-regulation of chemokine receptors on infection of CNS-derived cells, and on the induction of apoptosis. The last project, Drs. R. Collman and P. Crino will study the use of chemokine receptors in the regional compartmentalization of viral genotypes by amplification of proviral sequences from single cells in fixed brain from patients with HIVD. These projects will be supported by cores: (a) an administrative core that will be responsible for the overall conduct of the program, (b) a pathology core that will analyze the tissues from experimental animals and provide tissues to another project and (c) a cell culture core that will provide primary cell cultures to several projects. Together, the components of this program project will enhance our understanding of the virology and pathophysiology of HIVD, and provide novel therapeutic strategies for managing this complication.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Program Projects (P01)
Project #
5P01NS027405-12
Application #
6187223
Study Section
Special Emphasis Panel (ZNS1-SRB-P (03))
Program Officer
Kerza-Kwiatecki, a P
Project Start
1994-05-01
Project End
2004-08-31
Budget Start
2000-09-01
Budget End
2001-08-31
Support Year
12
Fiscal Year
2000
Total Cost
$1,186,296
Indirect Cost
Name
University of Pennsylvania
Department
Neurology
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Gannon, Patrick J; Akay-Espinoza, Cagla; Yee, Alan C et al. (2017) HIV Protease Inhibitors Alter Amyloid Precursor Protein Processing via ?-Site Amyloid Precursor Protein Cleaving Enzyme-1 Translational Up-Regulation. Am J Pathol 187:91-109
Akay, Cagla; Cooper, Michael; Odeleye, Akinleye et al. (2014) Antiretroviral drugs induce oxidative stress and neuronal damage in the central nervous system. J Neurovirol 20:39-53
Cook, Denise R; Gleichman, Amy J; Cross, Stephanie A et al. (2011) NMDA receptor modulation by the neuropeptide apelin: implications for excitotoxic injury. J Neurochem 118:1113-23
Gannon, Patrick; Khan, Muhammad Z; Kolson, Dennis L (2011) Current understanding of HIV-associated neurocognitive disorders pathogenesis. Curr Opin Neurol 24:275-83
Loftin, Lamorris M; Kienzle, Martha; Yi, Yanjie et al. (2011) R5X4 HIV-1 coreceptor use in primary target cells: implications for coreceptor entry blocking strategies. J Transl Med 9 Suppl 1:S3
Cross, Stephanie A; Cook, Denise R; Chi, Anthony W S et al. (2011) Dimethyl fumarate, an immune modulator and inducer of the antioxidant response, suppresses HIV replication and macrophage-mediated neurotoxicity: a novel candidate for HIV neuroprotection. J Immunol 187:5015-25
White, Michael G; Wang, Ying; Akay, Cagla et al. (2011) Parallel high throughput neuronal toxicity assays demonstrate uncoupling between loss of mitochondrial membrane potential and neuronal damage in a model of HIV-induced neurodegeneration. Neurosci Res 70:220-9
Loftin, Lamorris M; Kienzle, Martha F; Yi, Yanjie et al. (2010) Constrained use of CCR5 on CD4+ lymphocytes by R5X4 HIV-1: efficiency of Env-CCR5 interactions and low CCR5 expression determine a range of restricted CCR5-mediated entry. Virology 402:135-48
Cheung, Ricky; Malik, Mobeen; Ravyn, Vipa et al. (2009) An arrestin-dependent multi-kinase signaling complex mediates MIP-1beta/CCL4 signaling and chemotaxis of primary human macrophages. J Leukoc Biol 86:833-45
Yadav, Anjana; Collman, Ronald G (2009) CNS inflammation and macrophage/microglial biology associated with HIV-1 infection. J Neuroimmune Pharmacol 4:430-47

Showing the most recent 10 out of 150 publications